PATH: AI Automation And ARR Execution Will Drive Future Repricing

UiPath's analyst fair value estimate has been trimmed from $17.00 to about $16.29 as analysts adjust their price targets into a tighter $12 to $15 range. This reflects solid recent results, but also a preference to see stronger, more consistent ARR momentum and clearer AI driven benefits before becoming more positive.

Analyst Commentary

Recent research on UiPath points to a mixed but constructive tone, with most price targets now clustering in the low to mid teens and analysts looking closely at execution on Annual Recurring Revenue (ARR) and the real impact of AI related demand on growth and valuation.

Bullish analysts highlight that UiPath delivered what several described as solid or good fiscal Q1 results, with revenue coming in above their expectations and guidance for revenue and margins moving higher. These analysts see evidence that the company is executing against its current plan, even if ARR momentum and larger AI related deals are still viewed as areas where the company needs to show more progress over multiple quarters.

At the same time, there is an ongoing debate around how quickly AI driven automation demand can translate into stronger net new ARR and whether UiPath can show a more consistent pattern across its customer cohorts and pricing. Some analysts are holding neutral or equivalent ratings while they look for clearer signals that recent performance can be sustained and that newer pricing approaches, such as non seed based models, are gaining traction.

Valuation views are tied closely to this execution debate. Several firms have nudged price targets lower into a tighter range, reflecting a preference to see more evidence of durable ARR growth before assigning higher multiples. A few, however, point to UiPath trading at a discount to certain software peers and suggest that consistent progress on AI driven deals, enterprise adoption, and ARR trends could help close that gap over time if delivered.

Bullish Takeaways

• Bullish analysts point to UiPath’s fiscal Q1 revenue coming in above their estimates, along with raised full year guidance, as evidence that the company is currently executing in line with or slightly ahead of expectations on the top line.
• Some see larger AI driven deals and strength within enterprise cohorts as potential supports for net new ARR growth. If sustained, this could help justify valuations closer to the upper end of the current price target range.
• One major bank increased its UiPath price target, citing good quarterly results and an outlook that it viewed as supportive relative to the company’s current discount to certain infrastructure software peers.
• Bullish analysts indicate that additional data points showing a more consistent ARR growth trajectory, particularly tied to AI use cases, could support a more constructive stance on the stock over time.

What’s in the News for UiPath

• UiPath reported its first ever GAAP operating profit of US$28 million in fiscal Q1 FY2027, with AI playing a role in 16 of the top 20 deals and AI inclusive expansions generating roughly 6x more revenue. Management also highlighted perceived undervaluation through meaningful share repurchases. (Source: UiPath Price Forecast: PATH Posts First-Ever GAAP Profit as AI Deals Grow 6x Larger)
• New AI native Maestro Case capability was introduced within the Maestro orchestration platform to handle complex, exception heavy, long running workflows. Early adopters, such as a major New Zealand telecom, reported case handling time reductions of 60 to 80%, higher automation levels, and projected annual savings of more than US$12 million in financial services use cases. (Source: UiPath Launches AI-Native Maestro Case to Enhance Complex Enterprise Workflow Automation Amid Mixed Market Response)
• UiPath’s Q1 results across automation software peers were mixed, with revenue ahead of expectations but full year billings guidance described as weak relative to the group. This coincided with a stock price decline and contributed to more cautious commentary around forward recurring revenue expectations. (Source: A Look Back at Automation Software Stocks’ Q1 Earnings: UiPath (NYSE:PATH) Vs The Rest Of The Pack)
• Guidance for fiscal Q2 2027 and the full year was provided, with the company expecting revenue of US$395 million to US$400 million for the quarter and US$1.776b to US$1.781b for the year, giving investors concrete top line ranges to watch against future reported results.
• Alongside these financial updates, UiPath continued to roll out AI focused capabilities such as UiPath for Coding Agents and agentic AI features in Automation Suite, positioning its platform around orchestration of AI agents, software robots, and people across regulated and hybrid environments.

Valuation Changes for UiPath

• Fair Value: The analyst fair value estimate for UiPath moved from $17.00 to $16.29, a reduction of about 4.2% that keeps the figure within the previously discussed $12 to $15 target range.
• Discount Rate: The discount rate moved from 8.51% to 8.61%, a small increase that modestly raises the required return used in the valuation model.
• Revenue Growth: The revenue growth input shifted from 9.40% to 8.77%, a slight step down that implies a more conservative growth assumption in the model.
• Profit Margin: The profit margin assumption changed from 9.69% to 24.02%, a large uplift that reflects a materially higher long term profitability input.
• Future P/E: The future P/E multiple moved from 52.31x to 19.43x, a significant reduction that lowers the valuation placed on UiPath's projected earnings.